CORE HEALTH CARE NETWORK, INC. 10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

x	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2010

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission File Number

CORE HEALTH CARE NETWORK, INC.

(Exact name of Registrant as specified in its charter)

Nevada		26-3452407
(State or other jurisdiction of		(I.R.S. Employer Identification No.)
incorporation or organization)

For correspondence, please contact:

Jillian Ivey Sidoti, Esq.

34721 Myrtle Court

Winchester, CA 92596

(323) 799-1342 (phone)

(951) 602-6049 (fax)

200 S. Virginia Street – 8th Floor, Reno, NV		89501
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number: 877.862.0061

Indicate by check mark whether the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark whether the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	o	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). YES x NO o

As of April 11, 2011, no market price existed for voting and non-voting common equity held by non-affiliates of the registrant.

At April 11, 2011, there were 4,870,000 shares of Registrant's ordinary shares outstanding.

Document incorporated by reference: None.

FORWARD LOOKING STATEMENTS

In General

This Annual Report contains statements that plan for or anticipate the future. In this Annual Report, forward-looking statements are generally identified by the words "anticipate," "plan," "believe," "expect," "estimate," and the like. These forward-looking statements include, but are not limited to, statements regarding the following:

	*	our product and marketing plans;

	*	consulting and strategic business relationships;

	*	statements about our future business plans and strategies;

	*	anticipated operating results and sources of future revenue;

	*	our organization's growth;

	*	adequacy of our financial resources;

	*	development of new products and markets;

	*	competitive pressures;

	*	changing economic conditions;

	*	expectations regarding competition from other companies; and

	*	our ability to manufacture and distribute our products.

Although we believe that any forward-looking statements we make in this Annual Report are reasonable, because forward-looking statements involve future risks and uncertainties, there are factors that could cause actual results to differ materially from those expressed or implied. For example, a few of the uncertainties that could affect the accuracy of forward-looking statements, besides the specific factors identified above in the Risk Factors section of this Annual Report, include:

	*	changes in general economic and business conditions affecting the healthcare industry;

	*	the level of demand for our products; and capital available for acquisitions;

	*	changes in our business strategies;

In light of the significant uncertainties inherent in the forward-looking statements made in this Annual Report, particularly in view of our early stage of operations, the inclusion of this information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved.

PART I

Overview

CORE HEALTH CARE NETWORK, INC. (“we”, “us”, the “Company” or like terms) was incorporated in the State of Nevada on October 13, 2008 as Mickland, Inc. We are a developmental stage company and have not generated any revenues to date. Since inception, we have not engaged in any business operations other than development of our business plan. We have two officers and do not own any property.

We were organized to serve as a vehicle for a business combination through a merger, capital stock exchange, asset acquisition or other similar business combination (a “Business Combination”) with an operating or development stage business (the “Target Business”) which desires to utilize our status as a reporting company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Given that we have no assets, no current operations and our proposed business contemplates entering into a Business Combination with an operating company or purchasing an operating company, we are a “shell company,” which is defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”), as a company which has (i) no or nominal operations; and (ii) either (x) no or nominal assets; (y) assets consisting solely of cash and cash equivalents; or (z) assets consisting of any amount of cash and cash equivalents and nominal other assets.

We currently have several Business Combinations under consideration in the healthcare sector, specifically the physician owned primary care segment, medical imaging and diagnostic services, information technology, billing, and practice management functions.

Results of Operations for the Year Ended December 31, 2010

Assets

Currently, we have $150 in cash and $12,000 of prepaid consulting as our only assets. The prepaid consulting was paid in the form of stock options (not yet exercised) to Dr. H. Paul Hatten.

Operating Expense

Total operating expenses for the fiscal year ended December 31, 2010 were $79,674 compared to expenses from inception to December 31, 2010 of $95,293 and expenses of $6,619 for the year ended December 31, 2009. Most of these fees were related to professional fees, such as accounting and legal fees related to reporting as a public company; consulting fees for $15,000 to FTH Group at a rate of $5,000 per month since October of 2010; fees payable to board members for serving on the board of directors ($3,000 per month); wages and taxes payable to Pam McClanahan our Treasurer and Secretary ($3,500 per month) and to Lewis Warren, our president ($7,500 per month); and investment expenses.

In February, 2011, we entered into an acquisition agreement with MedTech, Inc. (as reported on our 8-k filed on February 22, 2011). However, during our internal audit review we found many inconsistencies in the financials and misrepresentations of items listed in the purchase agreement. The Board of Directors approved to rescind the acquisition and that process is underway.

Net Loss

Net loss for the fiscal year ended December 31, 2010 was $(79,674) compared to the period ended December 31, 2010 since inception of $(95,293). Net loss for the year ended December 31, 2009 was $(6,619).

Liquidity and Capital Resources

At December 31, 2010, we had $150 in cash.

Notes Payable

We have received various loans from Loftum, LLC totaling $17,863 as of December 31, 2010. The notes are unsecured, due on demand and bear interest at the rate of 8%. Loftum, LLC is a shareholder. The balance due to Loftum, LLC was $17,863 as of December 31, 2010. Accrued interest on this note was $1,955 as of December 31, 2010.

Additionally, on December 1, 2010, the Company acquired a letter of intent from ACE Diagnostics, LLC. ACE Diagnostics is a shareholder of the Company and is controlled by F. Tony Hosseini. The letter of intent required a note be issued in the amount of $100,000. The loan is unsecured, bears 6% interest beginning on January 1, 2011, and is due on demand. On December 20, 2010, the Company converted $2,250 of the note to 2,250,000 shares of common stock. The balance due to the shareholder was $97,750 as of December 31, 2010.

Critical Accounting Policies and Estimates

Our critical accounting policies are disclosed in our Form 10-K and the financial statements included in the 10-K. During the three months ended December 31, 2010 there have been no significant changes in our critical accounting policies.

Recent Accounting Pronouncements

Recent accounting pronouncements are disclosed in our Form 10-K and the financial statements included with the 10-K. During the three months ended December 31, 2010 there have been no new accounting pronouncements which are expected to significantly impact our consolidated financial statements.

PLAN OF OPERATION AND LIQUIDITY

General.

In August, 2010, we changed our name from Mickland, Inc. to Core Health Network, Inc. However, this has not resulted in a Business Combination and Core Health Care Network was not a Target Business. With this name change, we also issued 1,500,000 shares of stock to our new officers and directors. Please see our 8-K filed on August 2, 2010.

We are not presently engaged in, and we will not engage in, any substantive commercial business for an indefinite period until we identify a Target Business and enter into a Business Combination, if ever. On February 22, 2011, we filed a Form 8-K announcing our acquisition with MedTech, Inc. However, during our internal audit review we found many inconsistencies in the financials and misrepresentations of items listed in the purchase agreement. The Board of Directors approved to rescind the acquisition and that process is underway.

In October, 2010, we officially entered into employment agreements with our Secretary and Treasurer, Pam McClanahan, at a rate of $3,500 per month. We also entered into an employment agreement with our President, Lewis Warren, at a rate of $7,500. Due to a lack of capital, neither individual has been paid and their payments are accruing as liabilities.

We also entered into a consulting agreement with FTH Group which is controlled by our board member, Mr. F. Tony Hosseini. FTH Group is assisting with development of the business and searching for a possible business combination. A Business Combination may involve the acquisition of or merger with, a company which desires to have a class of securities registered under the Exchange Act, while avoiding what it may deem to be adverse consequences of undertaking a public offering itself. These include time delays, significant expenses, possible loss of voting control and compliance with various federal and state securities laws. As more fully described below under the heading “Form of acquisition; Opportunity for stockholder approval,” the proposed structure of any Business Combination may not require that we seek stockholder approval for the transaction and holders of our common stock may not have the opportunity to vote upon any such Business Combination.

On November 17, 2010, we entered into an agreement with Dr. H. Paul Hatten, who is also a shareholder of the Company, as a medical advisor. Dr. Hatten has received options for 200,000 shares of common stock exercisable at $0.05 per share for services valued at $12,000. Options for 100,000 shares expire on November 17, 2011 and the remaining options expire on November 17, 2012.

Transfer of Domains and Website Development.

Mr. Hosseini and Mr. Warren, in exchange for 500,000 common shares each at $.001 per share (total of $1,000), transferred two websites to the company for future company use and development. The websites are corehcn.com and corehealthtrack.com.

Assignment of Indian River Agreement.

On December 20, 2010, ACE Diagnostics, LLC (“ACE”), a company managed by shareholder, F. Tony Hosseini, assigned their interest in a letter of intent between ACE and Indian River Radiology, Inc. (“Indian River”) for ACE to acquire Indian River. In exchange for the assignment and for the efforts put forth with the potential acquisition of ACE, the Company entered into a promissory note with ACE for $100,000 at a rate of 6% per annum. This note is due upon demand.

There is no guarantee that the Company will acquire Indian River or that any kind of final agreement will be consummated.

Ttarget businessed or target industry

We have several businesses under review and consideration but other than those agreements discussed (Indian River and Medtech, Inc.) we have not selected any Target Business to enter into a Letter of Intent or Definitive Agreement. We continue to limit our search within the healthcare industry with a focus on primary care practices and diagnostic and preventive health products and services. We have conducted internal research with respect to identifying the number and characteristics of the potential Target Business candidates. However, we cannot assure you that we will be able to locate a Target Business or that we will be able to engage in a Business Combination with a Target Business on favorable terms.

We will have virtually unrestricted flexibility in identifying and selecting a prospective Target Business. We established specific attributes or criteria (financial or otherwise) for prospective Target Businesses. Although our management will endeavor to evaluate the risks inherent in a particular Target Business, we cannot assure you that we will properly ascertain or assess all significant risk factors.

Sources of target businesses.

Management expects that Target Business candidates brought to our attention from various unaffiliated sources, including members of the financial community, as well as accountants and attorneys who represent potential Target Business candidates. Target Business candidates may be brought to our attention by these unaffiliated sources as a result of being solicited by us through calls or mailings. These sources may also introduce us to Target Businesses candidates they think we may be interested on an unsolicited basis. Our officers and directors, as well as their affiliates, may also bring to our attention Target Business candidates of which they become aware through their business contacts, as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In no event will our existing officers and directors, or any entity with which any of them is affiliated, be paid any finder’s fee, in order to effectuate, the consummation of a Business Combination. After the effective date of this Registration Statement, we may engage the services of professional firms or other individuals that specialize in business acquisitions, in which event we may pay a finder’s fee, consulting fee or other compensation to be determined in an arm’s length negotiation. We have not adopted any policies with respect to utilizing the services of consultants or advisors to assist in the identification of a Target Business, the criteria to be used in selecting such consultants or advisors, the services to be provided, the term of service, or regarding the total amount of fees that may be paid. However, because of our limited resources, it is likely that any such fee we agree to pay would be paid in shares of our common stock or from the cash flow of the Business Combination.

Selection criteria of a Target Business.

Our management will have virtually unrestricted flexibility in identifying and selecting a prospective Target Business. We have established specific attributes or criteria (financial or otherwise) for prospective Target Businesses. In evaluating a prospective Target Business, our management will consider, among other factors, the following:

·	financial condition and results of operations;
·	growth potential;
·	experience and skill of management and availability of additional personnel;
·	capital requirements;
·	competitive position;
·	barriers to entry;
·	stage of development of the products, processes or services;
·	degree of current or potential market acceptance of the products, processes or services;
·	proprietary features and degree of intellectual property or other protection of the products, processes or services;
·	regulatory environment of the industry; and
·	costs associated with affecting the Business Combination.

These criteria are not intended to be exhaustive or to in any way limit the board of director’s unrestricted discretion to enter into a Business Combination with any Target Business. Any evaluation relating to the merits of a particular Business Combination will be based, to the extent relevant, on the above factors as well as other considerations deemed relevant by our management. In evaluating a prospective Target Business, we will conduct as extensive a due diligence review of potential targets as possible given the lack of information which may be available regarding private companies, our limited personnel and financial resources. We expect that our due diligence will encompass, among other things, meetings with the Target Business’s incumbent management and inspection of its facilities, as well as a review of financial and other information which is made available to us. This due diligence review will be conducted either by our management or by unaffiliated third parties we may engage. Our limited funds will likely make it impracticable to conduct a complete and exhaustive investigation and analysis of a Target Business candidate before we consummate a Business Combination. Management decisions, therefore, will likely be made without detailed feasibility studies, independent analysis, market surveys and the like which, if we had more funds available to us, would be desirable. We will be particularly dependent in making decisions upon information provided by the promoters, owners, sponsors, or others associated with the Target Business seeking our participation.

The time and costs required to select and evaluate a Target Business and to structure and complete the Business Combination cannot presently be ascertained with any degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective Target Business with which a Business Combination is not ultimately completed will result in a loss to us.

Lack of diversification.

In the initial stages of our business development, the prospects for our success may be entirely dependent upon the future performance of a single business and we will not benefit from the possible spreading of risks or offsetting of losses. By consummating a Business Combination with a single entity, our lack of diversification may:

·	subject us to numerous economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the company, and

·	result in our dependency upon the development or market acceptance of a single or limited number of products, processes or services.

Limited ability to evaluate the Target Business.

To a significant degree, our security holders will rely on management’s evaluation of a Target Business in making the decision to enter into a Business Combination. Management’s assessment of a Target Business will be based upon discussions with management of the Target Business and a review of due diligence material relating to the Target Business available to it during the evaluation period. Any such assessment may not be accurate.

Although we intend to scrutinize the management of a prospective Target Business when evaluating the desirability of effecting a Business Combination, we cannot assure you that our assessment of the Target Business’s management will prove accurate.

Given our current resources, we will likely seek a Business Combination with a privately-held company that is in the healthcare industry and focuses on primary care and diagnostic and preventive health products and services. Generally, very little public information exists about these companies and we will be required to rely on the ability of our management to obtain adequate information to evaluate the potential returns from entering into a Business Combination with such a company. If we do not uncover all material information about a Target Business prior to a Business Combination, we may not make a fully informed investment decision and we may lose money on our investment.

Form of acquisition; Opportunity for stockholder approval.

The manner in which we participate in a Business Combination will depend upon, among other things, the nature of the opportunity and the respective requirements and desires of management of our Company and of the Target Business. In addition, the structure of any Business Combination will be dispositive as to whether stockholder approval of the Business Combination is required.

It is likely that we will acquire our participation in a business opportunity by the acquisition of Target Company through the issuance of our common stock or other securities to the principals of the Target Business in exchange for all or part of the outstanding stock of the Target Company. In the case of an acquisition, the transaction may be accomplished in the sole determination of management without any vote or approval by stockholders.

Although the terms of an acquisition of a Target Business cannot be predicted, it is likely that we will seek to structure a Business Combination to qualify as a tax free transaction under the Internal Revenue Code of 1986, as amended (the "Code"). One such form of “tax free” transaction, if structured properly, entails the exchange of capital stock of the Target Business for our capital stock. Under Section 368(a)(1) of the Code, in order for a stock exchange transaction to qualify as a "tax free" reorganization, the holders of the stock of the target must receive a number of shares of our capital stock equal to 80% or more of the voting stock of our Company. If a transaction were structured to take advantage of these provisions rather than other "tax free" provisions provided under the Code, our existing stockholders would in such circumstances retain 20% or less of the total issued and outstanding shares of the surviving entity. Depending upon the relative negotiating strength of the parties, stockholders at the time of the Business Combination may retain substantially less than 20% of the total issued and outstanding shares of our Company. This could result in substantial additional dilution to the equity of those persons who were stockholders of our Company prior to such Business Combination.

In the case of a statutory merger or consolidation directly involving the Company, it might be necessary to call a stockholders' meeting and obtain the approval of the holders of a majority of the outstanding shares of common stock. The necessity to obtain stockholder approval may result in delay and additional expense in the consummation of any proposed transaction, which we may not be able to fund, and will also give rise to certain appraisal rights to dissenting stockholders. Accordingly, management will seek to structure any Business Combination so as not to require stockholder approval.

In the case of either an acquisition or merger, our stockholders prior to the consummation of a Business Combination likely will not have control of a majority of the voting shares of the Company following a Business Combination. As part of such a transaction, all or a majority of the Company's then director(s) may resign and new directors may be appointed without any vote by stockholders.

It is anticipated that the investigation of specific business opportunities and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial cost for accountants, attorneys and others. If a decision is made not to participate in a specific business opportunity, the costs incurred in the related investigation would not be recoverable. Furthermore, even if an agreement is reached for a Business Combination, the failure to consummate that transaction may result in the loss to the Company of the related costs incurred.

Competition.

Our ability to consummate a Business Combination will be constrained by our lack of financial resources to provide to the Target Business. We expect that in the course of identifying, evaluating and selecting a Target Business, we may encounter intense competition from other entities having a business objective similar to ours. These include blank check companies that may have raised significant sums through sales of securities registered under federal securities laws that are seeking to carry out a business plan similar to ours and possess a significant competitive advantage over us both from a financial and personnel perspective. Additionally, we may be subject to competition from entities other than blank check companies having a business objective similar to ours, including venture capital firms, leverage buyout firms and operating businesses looking to expand their operations through acquisitions. Many of these entities are well established and have extensive experience identifying and affecting business combinations directly or through affiliates. Moreover, nearly all of these competitors possess greater technical, human and other resources than us. In addition, we will experience competition from other modestly capitalized shell companies that are seeking to enter into business combinations with targets similar to those we expect to pursue.

While we believe there may be numerous potential target candidates with which we could affect a Business Combination, our ability to compete in affecting a Business Combination with prime candidates will be limited by our lack of financial resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of a Target Business.

If we succeed in effecting a Business Combination, there will be, in all likelihood, intense competition from competitors of the Target Business. We cannot assure you that, subsequent to a Business Combination, we will have the resources or ability to compete effectively.

Employees.

We have two executive officers and three directors and they have other business interests and are not obligated to devote any specific number of hours to our matters and intends to devote only as much time as they deem necessary to our affairs. Both officers entered into an employment agreement on October 1, 2010. Pamela McClanahan, our secretary and treasurer, entered into an agreement to be paid $3,500 per month. To date, Ms. McClanahan, due to the restrictions on Company cash, has not received any accrued compensation. Lewis C. Warren, our president, entered into an agreement to be paid $7,500 per month. To date, Mr. Warren, due the restrictions on Company cash, has not received any accrued compensation.

Our directors each shall receive $1,000 for serving on the board of directors. To date, no director has been compensated for their services.

The amount of time they will devote to our operations in any time period will vary based on whether a Target Business has been selected for the Business Combination and the stage of the Business Combination process the Company is in. Accordingly, once management locates a suitable Target Business, management will spend more time investigating such Target Business and negotiating and processing the Business Combination (and consequently spend more time on our affairs) than they would prior to locating a suitable Target Business. We do not intend to have any full time employees prior to the consummation of a Business Combination.

Our officers and directors may engage in other business activities similar and dissimilar to those we are engaged in without any limitations or restrictions applicable to such activities. To the extent that our management engages in such other activities, they may have possible conflicts of interest in diverting opportunities which would be appropriate for our Company to other companies, entities or persons with which they may be associated or have an interest, rather than diverting such opportunities to us. Since we have not established any policy for the resolution of such a conflict, we could be adversely affected should our officers and directors choose to place their other business interests before ours. We cannot assure you that such potential conflicts of interest will not result in the loss of potential opportunities or that any conflict will be resolved in our favor.

Periodic Reporting and Audited Financial Statements; Disclosure of Business Combination.

Upon the effective date of this Registration Statement, our class of common stock will be registered under the Exchange Act and we will have reporting obligations, including the requirement that we file annual, quarterly and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual reports will contain financial statements audited and reported on by our independent registered public accountants.

We will not acquire a Target Business if audited financial statements based on United States generally accepted accounting principles cannot be obtained for the Target Business. We cannot assure you that any particular Target Business identified by us as a potential acquisition candidate will have financial statements prepared in accordance with United States generally accepted accounting principles or that the potential Target Business will be able to prepare its financial statements in accordance with United States generally accepted accounting principles. To the extent that this requirement cannot be met, we may not be able to acquire the proposed Target Business. While this may limit the pool of potential acquisition candidates, we do not believe that this limitation will be material.

Upon the consummation of a Business Combination, the Company will file with the Securities and Exchange Commission a current report on Form 8-K to disclose the Business Combination, the terms of the transaction and a description of the business and management of the Target Business, among other things, and will include audited consolidated financial statements of the Company giving effect to the Business Combination. Holders of the Company’s securities will be able to access the Form 8-K and other filings made by the Company on the EDGAR Company Search page of the Securities and Exchange Commission’s Web site, the address for which is “www.sec.gov.”

Item 1A. Risk Factors

An investment in the Company is highly speculative in nature and involves an extremely high degree of risk.

We are a development stage company with no revenues and, accordingly, you will not have any basis on which to evaluate our ability to achieve our business objective.

We incorporated in late 2008 and are a development stage company with no income to date. You will have no basis upon which to evaluate our ability to achieve our business objective, which is to acquire an operating business. We have conducted discussions with prospective acquisition candidates, however we may be unable to complete a Business Combination. We will not generate any revenues until, at the earliest, after the consummation of a Business Combination, if at all.

We will be deemed a blank check company under Rule 419 of the Securities Act of 1933. In any subsequent offerings, we will have to comply with Rule 419.

If we publicly offer any securities as a condition to the closing of any acquisition or business combination while we are a blank check or shell company, we will have to fully comply with SEC Rule 419 and deposit all funds in escrow pending advice about the proposed transaction to our stockholders fully disclosing all information required by Regulation 14 of the SEC and seeking the vote and agreement of investment of those stockholders to whom such securities were offered; if no response is received from these stockholders within 45 days thereafter or if any stockholder elects not to invest following our advice about the proposed transaction, all funds that must be held in escrow by us under Rule 419, as applicable, will be promptly returned to any such stockholder. All securities issued in any such offering will likewise be deposited in escrow, pending satisfaction of the foregoing conditions. This is only a brief summary of Rule 419.

Our future success is highly dependent on the ability of management to complete a Business Combination with a Target Business that generates revenue and otherwise operates profitably.

The nature of our operations is highly speculative. The future success of our plan of operation will depend entirely on the operations, financial condition and management of the Target Business we may acquire. While management intends to seek to enter into a Business Combination with an entity having an established operating history, we cannot assure you that we will be successful in consummating a Business Combination with a candidate that meets that criterion. In the event we complete a Business Combination, the success of our operations will be dependent upon management of the Target Business and numerous other factors beyond our control.

The Company has no existing agreement for a Business Combination or other transaction.

We have no arrangement, agreement or understanding with respect to engaging in a Business Combination with an operating entity. On February 22, 2011, on a Form 8-k, we reported a Business Combination with MedTech, Inc. However, during our internal audit review we found many inconsistencies in the financials and misrepresentations of items listed in the purchase agreement. The Board of Directors approved to rescind the acquisition and that process is underway. We also were assigned the rights in a Letter of Intent to acquire Indian River Radiology.

We cannot assure you that we will successfully identify and evaluate suitable business opportunities or that we will conclude a Business Combination.

The time and cost of preparing a private company to become a public reporting company may preclude us from entering into a Business Combination with the most attractive private companies.

Target companies that fail to comply with SEC reporting requirements may delay or preclude a Business Combination. Sections 13 and 15(d) of the Exchange Act require reporting companies to provide certain information about significant acquisitions, including audited financial statements for the company acquired. The time and additional costs that may be incurred by some target entities to prepare these statements may significantly delay or essentially preclude consummation of a Business Combination. Otherwise suitable acquisition prospects that do not have or are unable to obtain the required audited statements may be inappropriate for acquisition so long as the reporting requirements of the Exchange Act are applicable.

We will have no revenues unless and until we enter into a Business Combination with an operating company that is generating revenues and otherwise is operating profitably.

We are a development stage company and have had no revenues from operations. We will not realize any revenues or generate any income unless and until we successfully merge with or acquire an operating business that is generating revenues and otherwise is operating profitably, if ever. We cannot assure you that we will be successful in concluding a Business Combination with an operating entity that is at the time of the transaction generating revenues.

We likely will complete only one Business Combination, which will cause us to be dependent solely on a single business and a limited number of products, services or assets.

Given our limited financial resources and other considerations, it is likely we will complete a Business Combination with only one Target Business. Accordingly, the prospects for our success may be

solely dependent upon the performance of a single business and dependent upon the development or market acceptance of a single or limited number of products, processes or services. In this case, we will not be able to diversify our operations or benefit from the possible diversification of risks or offsetting of losses, unlike other entities which may have the resources to complete several Business Combinations or asset acquisitions in different industries or different areas of a single industry so as to diversify risks and offset losses.

Given our limited resources and the significant competition for Target Businesses we may not be able to consummate an attractive Business Combination.

We could encounter intense competition from other entities having a business objective similar to ours, including blank check companies, finance companies, banks, venture capital funds, leveraged buyout funds, operating businesses and other financial buyers competing for acquisitions. Many of these entities are well established and have extensive experience in identifying and affecting Business Combinations directly or through affiliates. Nearly all of these competitors possess greater technical, human and other resources than we do and our financial resources will be negligible when contrasted with those of many of these competitors. In addition, we will experience direct competition from other modestly capitalized shell companies that are seeking to enter into business combinations with targets similar to those we expect to pursue, Our Company has not adopted any policy with respect to resolving any potential conflict of interest and it is possible that any conflict or interest that arises may not be decided in our favor.

It is likely that we will consummate a Business Combination with a private company for which limited information will be available to conduct due diligence.

We likely will seek a Business Combination with a privately-held company. Generally, very little public information exists about these companies or their management, and we will be required to rely on the ability of our management to obtain adequate information to evaluate the potential success of entering into a transaction with such a company. In addition, our management will only devote limited time to the business of the Company and will have available to it extremely limited financial resources with which to conduct due diligence. If our assessment of the Target Business’s operations and management is inaccurate or we are unable to uncover all material information about these companies, then we may not make a fully informed investment decision, and we may lose money.

If we consummate a Business Combination by way of an acquisition, we will not be required to submit such transaction to a vote of our stockholders.

If we consummate a Business Combination by way of an acquisition of the capital stock or assets of the Target Business, the transaction may be accomplished in the sole determination of management without any vote or approval by stockholders. Accordingly, holders of our securities at the time of any Business Combination may not have an opportunity to evaluate the Target Business or its management and will have to rely on the judgment of management in assessing the future profitability and viability of the Target Business.

A Business Combination with a foreign company may subject us to additional risks.

If we enter into a Business Combination with a foreign entity, we will be subject to risks inherent in business operations outside of the United States. These risks include:

·	unexpected changes in, or impositions of, legislative or regulatory requirements;

·	foreign currency exchange rate fluctuations;

·	potential hostilities and changes in diplomatic and trade relationships;

·	changes in duties and tariffs, taxes, trade restrictions, license obligations and other non-tariff barriers to trade;

·	burdens of complying with a wide variety of foreign laws and regulations;

·	longer payment cycles and difficulties collecting receivables through foreign legal systems;

·	difficulties in enforcing or defending agreements and intellectual property rights;

·	reduced protection for intellectual property rights in some countries;

·	potentially adverse tax consequences;

·	the ability of our stockholders to obtain jurisdiction over non-US based directors and officers; and

·	political and economic instability.

If the Target Business is not successful managing these risks among others, the Company’s business after the Business Combination may be negatively impacted.

Our long-term success will likely be dependent upon a yet to be identified management team which may be difficult to fully evaluate.

In the event we complete a Business Combination, the success of our operations will be dependent upon management of the Target Business and numerous other factors beyond our control. Although it is possible that our management will remain associated with the Target Business following a Business Combination, it is likely that the management team of the Target Business at the time of the Business Combination will remain in place given that they will have greater knowledge, experience and expertise than our management in the industry in which the Target Business operates as well as in managing the Target Business. Thus, even though our management may continue to be associated with us after a Business Combination, it is likely that we will be dependent upon a yet to be identified management team for our long-term success. As a result, you will not be able to fully evaluate the management team that we will likely be dependent upon for our long-term success prior to any Business Combination. Although we intend to scrutinize management of a prospective Target Business as closely as possible in connection with evaluating the desirability of affecting a Business Combination, we cannot assure you that our assessment of the management team will prove to be correct. These individuals may be unfamiliar with the requirements of operating a public company and the securities laws, which could increase the time and resources we must expend to assist them in becoming familiar with the complex disclosure and financial reporting requirements imposed on U.S. public companies. This could be expensive and time-consuming and could lead to various regulatory issues that may adversely affect our operations.

If we affect a Business Combination with a financially unstable company or an entity in the early stage of development or growth, we will be subject to greater risks than if we were to affect a Business Combination with a more established company with a proven record of earnings and growth.

Given our financial and personnel resources compared to our competitors, we may be limited to consummating a Business Combination with a company that is financially unstable or is in the early stage of development or growth, including an entity without established records of sales or earnings. To the extent we affect a Business Combination with a financially unstable or early stage or emerging growth company, we may be impacted by numerous risks inherent in the business and operations of such company that we would not be subject to if we were to effect a Business Combination with a more established company with a proven record of earnings and growth.

If we are unable to structure the Business Combination as a “tax free” transaction, potential Target Businesses could be deterred from entering into such a transaction.

We may not be able to structure our acquisition to result in tax-free treatment for the companies or their stockholders, which could deter third parties from entering into certain Business Combinations with us. Currently, a transaction may be structured so as to result in tax-free treatment to both companies, as prescribed by various federal and state tax provisions. We intend to structure any Business Combination so as to minimize the federal and state tax consequences to both us and the Target Business; however, we cannot guarantee that the Business Combination will meet the statutory requirements of a tax-free reorganization or that the parties will obtain the intended tax-free treatment upon a transfer of stock or assets. A non-qualifying reorganization could result in the imposition of both federal and state taxes that may have an adverse effect on both parties to the transaction.

We expect to issue a significant number of new shares of our capital stock in a Business Combination, which will result in substantial dilution and a change in control of ownership of the Company.

Our Articles of Incorporation authorizes the issuance of a maximum of 100,000,000 shares of common stock and a maximum of 10,000,000 shares of preferred stock. Any Business Combination effected by us may result in the issuance of additional securities without stockholder approval and may result in substantial dilution in the percentage of our common stock held by our then existing stockholders. In order to structure a Business Combination as a tax free transaction, federal tax laws require that the holders of the stock of the target must receive a number of shares of our capital stock equal to 80% or more of the voting stock of our Company, in which case our existing stockholders would in such circumstances retain 20% or less of the total issued and outstanding shares of the surviving entity, though it is likely they could own far less than 20% of our outstanding common stock after giving effect to a Business Combination. Moreover, the common stock issued in any such merger or acquisition transaction may be valued on an arbitrary or non-arm's-length basis by our management, resulting in an additional reduction in the percentage of common stock held by our then existing stockholders. Our board of directors has the power to issue any or all of such authorized but unissued shares without stockholder approval. To the extent that additional shares of common stock or preferred stock are issued in connection with a Business Combination or otherwise, dilution to the interests of our stockholders will occur and the rights of the holders of common stock might be materially adversely affected

We have not conducted any third party market research or identification of business opportunities, which may affect our ability to identify a Target Business.

We have not retained any third party professionals to conduct nor have others made available to us results of market research concerning prospective business opportunities. Therefore, we have no assurances that market demand exists for a Business Combination other than our own internal studies. Our management has several businesses under consideration. Combination or other transactions for formal evaluation by us, such that it may be expected that any such target business or transaction will present such a level of risk that conventional private or public offerings of securities or conventional bank financing will not be available. There is no assurance that we will be able to enter into a Business Combination on terms favorable to us. Decisions as to which business opportunity to participate in will be unilaterally made by our management, which may, in many instances, act without the consent, vote or approval of our stockholders.

Our officers and directors will apportion their time to other businesses which may cause conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to consummate a Business Combination.

Our officers and directors engage in other businesses and are not required to devote their full time or any specific number of hours to our affairs, which could create a conflict of interest when allocating their time between our operations and their other commitments. We do not have and do not expect to have any full time employees prior to the consummation of a Business Combination.

Our management currently is and may in the future become affiliated with entities engaged in business activities similar to those conducted by us and accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.

Our management may in the future become affiliated with entities, including blank check or shell companies, engaged in business activities similar to those intended to be conducted by us. Additionally, our management may become aware of business opportunities which may be appropriate for presentation to us as well as the other entities to which they owe fiduciary duties. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. We cannot assure you that these conflicts will be resolved in our favor. As a result, a potential Target Business may be presented to another entity prior to its presentation to us and we may not be able to pursue a potential transaction.

Limitations on liability and indemnification matters.

As permitted by the corporate laws of the State of Nevada, we have included in our Articles of Incorporation a provision to eliminate the personal liability of our directors for monetary damages for breach or alleged breach of their fiduciary duties as directors, subject to certain exceptions. In addition, our By-Laws provide that we are required to indemnify our officers and directors under certain circumstances, including those circumstances in which indemnification would otherwise be discretionary, and we will be required to advance expenses to our officers and directors as incurred in connection with proceedings against them for which they may be indemnified.

There is currently no trading market for our common stock.

All outstanding shares of our common stock are “restricted securities,” as that term is defined under Rule 144 promulgated under the Securities Act, because they were issued in a private transaction not involving a public offering, and cannot be offered, sold, pledged or otherwise transferred unless subsequently registered pursuant to, or exempt from registration under, the Securities Act of 1933, as amended, (the "Securities Act") and any other applicable federal or state securities laws or regulations. As to shares of our common stock held by affiliates and their permitted transferees, the Securities and Exchange Commission has taken the position that Rule 144 is not available for the resale of securities in shell companies held by those persons, either before and after a Business Combination, despite technical compliance with the requirements of Rule 144 because those persons would be acting as "underwriters" under the Securities Act when reselling their securities. Accordingly, resale transactions of shares held by our affiliates and their permitted transferees, would need to be made through a registered offering of such securities. These restrictions will limit the ability of our current stockholders to liquidate their investment.

We cannot assure you that following a Business Combination with an operating business, our common stock will be listed or admitted to quotation on any securities exchange or other trading medium.

Following a Business Combination, then management of the Company may seek to develop a public market for our common stock. However, we cannot assure you that following such a transaction, the Company will be able to meet the initial listing standards of any stock exchange or that our common stock will be admitted for quotation on the over the counter bulletin board or any other trading medium. The Company’s common stock does not trade publicly, holders may not be able to sell their common stock. Moreover, our common stock may be deemed to be a “penny stock” and subject to the SEC’s penny stock rule which provides that, if our common stock failed to meet the criteria set forth in such rule, brokers would be subject to various practice requirements which would limit the sale of our stock only to persons who were established customers and accredited investors. Consequently, such rule may deter broker-dealers from recommending or selling our common stock, which may further affect its liquidity. This would also make it more difficult for us to raise additional capital following a Business Combination.

We have never paid dividends on our common stock.

We have never paid dividends on our common stock and do not presently intend to pay any dividends in the foreseeable future. In the unlikely event we generated profits prior to a Business Combination, we expect to retain such earnings and re-invest them into the Company to further its business strategy.

Authorization of Preferred Stock.

Our Articles of Incorporation authorize the issuance of up to 10,000,000 shares of preferred stock with such designations, rights and preferences determined from time to time by the board of directors. Accordingly, our board of directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the holders of the common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying or preventing a change in control of the Company.

There are risks associated with forward-looking statements made by us and actual results may differ.

Some of the information in this Registration Statement contains forward-looking statements that involve substantial risks and uncertainties. These statements can be identified by the use of forward-looking words such as “may”, “will”, “expect”, “anticipate”, “believe”, “estimate”, and “continue”, or similar words. Statements that contain these words should be read carefully because they:

·	discuss our future expectations;

·	contain projections of our future results of operations or of our financial condition; and

·	state other “forward-looking” information.

We believe it is important to communicate our expectations. However, there may be events in the future that we are not able to accurately predict and/or over which we have no control. The risk factors listed in this section, other risk factors about which we may not be aware, as well as any cautionary language in this Registration Statement, provide examples of risks, uncertainties, and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. The occurrence of the events described in these risk factors could have an adverse effect on our business, results of operations, and financial condition.

ITEM 1B. UNRESOLVED STAFF COMMENTS.

None

ITEM 2. DESCRIPTION OF PROPERTY

We maintain our principal executive offices at 200 S. Virginia Street – 8th Floor, Reno, NV 89501. Starting in December 31, 2010, we entered into an agreement to use this office space for $79 per month. We believe that this space is sufficient for our current requirements. The Company does not own any properties at this time and does not anticipate owning or leasing any additional properties prior to the consummation of a Business Combination, if ever.

ITEM 3. LEGAL PROCEEDINGS

There are no material legal proceedings in which either we or any of our affiliates are involved which could have a material adverse effect on our business, financial condition or future operations.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None, except as previously disclosed.

PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Market Information

As of the date of this Registration Statement, there are 4,870,000 outstanding shares of our common stock.

The Company's common stock does not trade, nor is it admitted to quotation, on any stock exchange or other trading facility. Management has no present plan, proposal, arrangement or understanding with any person with regard to the development of a trading market in any of our securities. We cannot assure you that a trading market for our common stock will ever develop. The Company has not registered its class of common stock for resale under the blue sky laws of any state and current management does not anticipate doing so. The holders of shares of common stock, and persons who may desire to purchase shares of our common stock in any trading market that might develop in the future, should be aware that significant state blue sky law restrictions may exist which could limit the ability of stockholders to sell their shares and limit potential purchasers from acquiring our common stock.

All outstanding shares of our common stock are “restricted securities,” as that term is defined under Rule 144 promulgated under the Securities Act, because they were issued in a private transaction not involving a public offering. All of our outstanding shares of our common stock are held by affiliates. As to shares of our common stock held by affiliates and their permitted transferees, the Securities and Exchange Commission has taken the position that Rule 144 is not available for the resale of securities held by those persons, either before and after a Business Combination, despite technical compliance with the requirements of Rule 144 because those persons would be acting as "underwriters" under the Securities Act when reselling their securities. Accordingly, resale transactions of shares held by our affiliates and their permitted transferees, would need to be made through a registered offering of such securities. The Company is not obligated to register any shares of capital stock for public resale under the Securities Act of 1933, as amended.

Neither the Company nor its officer and director has any present plan, proposal, arrangement, understanding or intention of selling any unissued or outstanding shares of common stock in the public market subsequent to a Business Combination. Nevertheless, in the event that a substantial number of shares of our common stock were to be sold in any public market that may develop for our securities subsequent to a Business Combination, such sales may adversely affect the price for the sale of the Company's common stock securities in any such trading market. We cannot predict what effect, if any, market sales of currently restricted shares of common stock or the availability of such shares for sale will have on the market prices prevailing from time to time, if any.

Dividends

We have not paid any dividends on our common stock to date and do not presently intend to pay cash dividends prior to the consummation of a Business Combination. It is the present intention of our management to retain all earnings, if any, for use in our business operations.

The payment of any dividends subsequent to a Business Combination will be within the discretion of our then seated board of directors. Current management cannot predict the factors which any future board of directors would consider when determining whether or when to pay dividends.

EQUITY COMPENSATION PLAN INFORMATION

Recent Sales of Unregistered Securities

The issuance of the common stock to certain shareholders was exempt from registration under the Securities Act pursuant to Section 4(2) and Regulation D thereof. We made this determination based on the representations of the shareholders which included, in pertinent part, that such shareholder was acquiring our common stock, for investment purposes for its own account and not as nominee or agent, and not with a view to the resale or distribution thereof, and that such shareholder understood that the shares of our common stock may not be sold or otherwise disposed of without registration under the Securities Act or an applicable exemption therefrom.

On November 16, 2010, the Company issued 70,000 shares of common stock at $0.001 per share for cash proceeds of $70 to Patty Johnson for her previous service as an officer of the Company and to Pamela McClanahan for her ongoing services to the Company.

On November 17, 2010, the Company issued 50,000 shares of common stock at $0.05 per share for cash proceeds of $2,500 to Dr. H. Paul Hatten, Jr.

On November 17, 2010, the Company granted 200,000 stock options for consulting services to Dr. H. Paul Hatten, Jr. valued at $12,000. The options have an exercise price of $0.05 with 100,000 options expiring on November 17, 2011 and the remaining 100,000 options expiring on November 17, 2012.

On December 20, 2010, the Company issued 2,250,000 shares of common stock at $0.001 per share to convert $2,250 of the ACE Diagnostics, LLC shareholder note payable. ACE Diagnostics, LLC is managed by our director, Tony Hosseini.

On December 20, 2010, the Company issued 350,000 shares to various shareholders in exchange for $350.

ITEM 6. SELECTED FINANCIAL DATA

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Certain statements in this Management's Discussion and Analysis of Financial Condition and Results of Operations which are not historical facts are forward-looking statements such as statements relating to future operating results, existing and expected competition, financing and refinancing sources and availability and plans for future development or expansion activities and capital expenditures. Such forward-looking statements involve a number of risks and uncertainties that may significantly affect our liquidity and results in the future and, accordingly, actual results may differ materially from those expressed in any forward-looking statements. Such risks and uncertainties include, but are not limited to, those related to effects of competition, maintaining sufficient working capital for our operations, and the general economic conditions and environment in which we operate. The following discussion and analysis should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this report.

Overview

The following discussion shoud be read in conjunction with our financial statements and the related notes that appear elsewhere in this prospectus. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed below and elsewhere in this prospectus, particularly in the section entitled "Risk Factors".

Management’s Discussion and Analysis of Financial Statements and Results of Operations.

Business Overview.

The Company was organized as a vehicle to enter into a Business Combination with a Target Business that is seeking the advantages of having a class of stock registered under federal securities laws. The Company does not currently engage in any business activities that provide cash flow. Our principal business objective for the next twelve months and beyond will be to achieve long-term growth potential through a combination with an operating business rather than immediate, short-term earnings. The Company will not restrict its potential candidate Target Businesses to any specific business, industry or geographical location and, thus, may acquire any type of business.

On February 22, 2011, the Company filed an 8-K discussing their acquisition of MedTech, Inc. However, during our internal audit review we found many inconsistencies in the financials and misrepresentations of items listed in the purchase agreement. The Board of Directors approved to rescind the acquisition and that process is underway. Subsequently, no assets have been meaningfully exchanged.

The Company continues to search for Target Business to acquire. As of the date of this Registration Statement, we have several businesses under consideration but have not selected any Target Business for a Business Combination. On December 1st, 2010 Ace Diagnostics, LLC, which is managed by our director, Tony Hosseini, assigned to us its interest in a non-binding letter of intent with Indian River Radiology, PA

In November, 2010, the Company entered into a consulting agreement with Dr. H. Paul Hatten, who also serves on our Advisory Board as a medical advisor. Dr. Hatten has not yet provided any consulting services to date.

Management expects that the selection of a Target Business will be a complex, competitive and extremely risky matter. Because of general economic conditions, rapid technological advances being made in some industries and shortages of available capital, our management believes that there are numerous firms seeking even the limited additional capital which we will have and/or the perceived benefits of becoming a publicly traded corporation. Such perceived benefits of having a class of securities registered under federal securities laws which include, among other things, facilitating or improving the terms on which additional equity financing may be obtained, creating a means for providing incentive stock options or similar benefits to key employees, and offering greater flexibility in structuring acquisitions, joint ventures and the like through the issuance of capital stock. Target Businesses may be available in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult.

Assets

Currently, the only tangible asset we have is cash of $150.

Liquidity and Capital Resources

At December 31, 2010, we had $150 in cash. We anticipate that our total operating expenses will be approximately $428,948 for the next twelve months. This includes our estimated expenses as follows:

·	our estimated expenses of $50,000 related with identifying a Business Combination;

·	our estimated expenses of $50,000 for our audit fees for the next twelve months; and

·	our estimated expenses of $100,000 for our legal and organization fees for the next twelve months;

·	our estimated expenses of $132,000 for employment costs payable to our president and our secretary/treasurer

·	our estimated expenses of $36,000 for fees payable to our board members for their service to our board;

·	our estimated expenses of $60,000 for fees payable to FTH Group for consulting services per our contract with them;

·	our estimated expenses of $948 for maintaining our Reno offices.

To date, we have funded our operations through loans from our stockholders. During the next twelve months we anticipate incurring costs and expenses related to filing of Exchange Act reports and investigating and consummating a Business Combination. Management and our stockholders expect to fund additional costs and expenses which may be incurred in connection with due diligence activities and a Business Combination through further loans or investment in the Company, as and when necessary. We cannot provide investors with any assurance that we will have sufficient capital resources to identify a suitable Target Business, to conduct effective due diligence as to any Target Business or to consummate a Business Combination.

Results of Operations.

Since our inception, we have not engaged in any activities other than in connection with our organization and preparing and filing this Registration Statement and have not generated any revenues to date. We do not expect to engage in any activities, other than seeking to identify a Target Business, unless and until such time as we enter into a Business Combination with a Target Business, if ever. We cannot provide investors with any assessment as to the nature of a Target Business’s operations or speculate as to the status of its products or operations, whether at the time of the Business Combination it will be generating revenues or its future prospects.

Personnel

Pamela McClanahan, our secretary and treasurer, is working approximately 20 hours per week to meet our needs. As demand requires, Ms. McClanahan will devote additional time. Lewis C. Warren, our president and director, is dedicating approximately 20-30 hours per week. As demand requires, Mr. Warren will devote additional time. We currently have no other employees.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable

ITEM 8. FINANCIAL STATEMENTS

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

TABLE OF CONTENTS

DECEMBER 31, 2010

Report of Independent Registered Public Accounting Firm	F-1

Balance Sheets as of December 31, 2010 and 2009	F-2

Statements of Operations for the periods ended December 31, 2010 and 2009 and for the period from October 13, 2008 (date of inception) to December 31, 2010	F-3

Statement of Stockholders’ Deficit as of December 31, 2010	F-4

Statements of Cash Flows for the periods ended December 31, 2010 and 2009 and for the period from October 13, 2008 (date of inception) to December 31, 2010	F-5

Notes to Financial Statements	F-6 to F-10

Silberstein Ungar, PLLC CPAs and Business Advisors

Phone (248) 203-0080

Fax (248) 281-0940

30600 Telegraph Road, Suite 2175

Bingham Farms, MI 48025-4586

www.sucpas.com

Report of Independent Registered Public Accounting Firm

To the Board of Directors of

Core Health Care Network, Inc.

Reno, Nevada

We have audited the accompanying balance sheets of Core Health Care Network, Inc. (the “Company”) as of December 31, 2010 and 2009, and the related statements of operations, stockholders’ deficit, and cash flows for the years then ended and the period from October 13, 2008 (Date of Inception) through December 31, 2010. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Core Health Care Network, Inc. as of December 31, 2010 and 2009 and the results of its operations and its cash flows for the years then ended and the period from October 13, 2008 (Date of Inception) through December 31, 2010 in conformity with accounting principles generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 11 to the financial statements, the Company has negative working capital, has received no revenue from sales of products or services, and has incurred losses from operations since inception. These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans with regard to these matters are described in Note 11. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Silberstein Ungar, PLLC

Bingham Farms, Michigan

March 21, 2011

F-1

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEETS

AS OF DECEMBER 31, 2010 AND 2009

ASSETS	December 31, 2010			December 31, 2009

Current Assets
Cash and equivalents	$	150		$	100
Prepaid consulting		12,000			0
		12,150			100

Other Assets
Website domain names, net		1,000			0
Assignment – letter of intent		100,000			0
Total Other Assets		101,000			0

TOTAL ASSETS	$	113,150		$	100

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Liabilities
Current Liabilities
Accrued expenses		50,189			3,000
Accrued expenses – related parties		24,222			0
Accrued interest – shareholders		1,955			704
Notes payable – shareholders		115,613			12,619
Total current liabilities		191,979			16,323

Stockholders’ Deficit
Preferred Stock, $.0001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding		0			0
Common Stock, $.0001 par value, 100,000,000 shares authorized, 4,870,000 and 1,000,000 shares issued and outstanding, respectively		487			100
Additional paid-in capital		17,933			0
Deficit accumulated during the development stage		(97,249	)		(16,323	)
Total stockholders’ deficit		(78,829	)		(16,223	)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	113,150		$	100

See accompanying notes to financial statements.

F-2

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009

PERIOD FROM OCTOBER 13, 2008 (INCEPTION) TO DECEMBER 31, 2010

	Year ended December 31, 2010			Year ended December 31, 2009			Period from October 13, 2008 (inception) to December 31, 2010

REVENUES	$	0		$	0		$	0

OPERATING EXPENSES
Professional fees		12,250			6,619			27,869
Consulting fees		15,000			0			15,000
Directors’ fees		9,000			0			9,000
Investment expenses		5,000			0			5,000
Wages and taxes		36,001			0			36,001
Filing fees		1,467			0			1,467
General and administrative		956			0			956
TOTAL OPERATING EXPENSES		79,674			6,619			95,293

LOSS FROM OPERATIONS		(79,674	)		(6,619	)		(95,293	)

OTHER EXPENSES
Interest expense		1,252			653			1,956
TOTAL OTHER EXPENSES		1,252			653			1,956

NET LOSS BEFORE PROVISION FOR INCOME TAXES		(80,926	)		(7,272	)		(97,249	)

PROVISION FOR INCOME TAXES		0			0			0

NET LOSS	$	(80,926	)	$	(7,272	)	$	(97,249	)

NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.05	)	$	(0.01	)

WEIGHTED AVERAGE SHARES OUTSTANDING: BASIC AND DILUTED		1,680,740			1,000,000

See accompanying notes to financial statements.

F-3

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

STATEMENT OF STOCKHOLDERS’ DEFICIT

PERIOD FROM OCTOBER 13, 2008 (INCEPTION) TO DECEMBER 31, 2010

	Common Stock				Additional Paid in		Stock Subscription			Deficit Accumulated During the Development
	Shares		Amount		Capital		Receivable			Stage			Total

Issuance of common stock @ $.0001 at inception		1,000,000	$	100	$	0	$	(100	)	$	0		$	0

Net loss for the period ended December 31, 2008		-		-		-		-			(9,051	)		(9,051	)

Balance, December 31, 2008		1,000,000		100		0		(100	)		(9,051	)		(9,051	)

Cash received for stock subscription		-		-		-		100			-			100

Net loss for the year ended December 31, 2009		-		-				-			(7,272	)		(7,272	)

Balance, December 31, 2009		1,000,000		100		0		0			(16,323	)		(16,223	)

Shares issued for cash at $0.001 per share		570,000		57		513		-			-			570

Shares issued for cash at $0.05 per share		50,000		5		2,495		-			-			2,500

Shares issued for website domain names at $0.001 per share		1,000,000		100		900		-			-			1,000

Shares issued for debt conversion at $0.001 per share		2,250,000		225		2,025		-			-			2,250

Stock options issued for services		-		-		12,000		-			-			12,000

Net loss for the year ended December 31, 2010											(80,926	)		(80,926	)

Balance, December 31, 2010		4,870,000	$	487	$	17,933	$	0		$	(97,249	)	$	(78,829	)

See accompanying notes to financial statements.

F-4

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009

PERIOD FROM OCTOBER 13, 2008 (INCEPTION) TO DECEMBER 31, 2010

	Year ended December 31, 2010			Year ended December 31, 2009			Period from October 13, 2008 (inception) to December 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$	(80,926	)	$	(7,272	)	$	(97,249	)
Change in non-cash working capital items:
Increase (decrease) in accrued expenses and interest		47,189			(2,000	)		50,189
Increase in accrued expenses – related parties		24,222			0			24,222
Increase in accrued interest – related party		1,251			653			1,955
NET CASH USED IN OPERATING ACTIVITIES		(8,264	)		(8,619	)		(20,883	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable – shareholder		5,244			8,619			17,863
Proceeds from sales of common stock		3,070			100			3,170
NET CASH PROVIDED BY FINANCING ACTIVITIES		8,314			8,719			21,033

NET INCREASE IN CASH		50			100			150

CASH, BEGINNING OF PERIOD		100			0			0
CASH, END OF PERIOD	$	150		$	100		$	150

SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid	$	0		$	0		$	0
Income taxes paid	$	0		$	0		$	0

SUPPLEMENTAL NON-CASH INVESTING AND FINANCING INFORMATION
Shares issued to acquire website domain names	$	1,000		$	0		$	1,000
Issuance of note payable in connection with letter of intent to acquire Indian River Radiology, LLC	$	100,000		$	0		$	100,000
Conversion of debt to common stock	$	2,250		$	0		$	2,250
Stock options issued for future services and recorded as prepaid consulting	$	12,000		$	0		$	12,000

See accompanying notes to financial statements.

F-5

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2010

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

Core Health Care Network, Inc. (the “Company or “Core”) is a development stage company and was incorporated in Nevada on October 13, 2008. The Company’s objective is to acquire operating healthcare related businesses in a business combination.

Development Stage Company

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles related to development stage companies. A development-stage company is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars.

Accounting Basis

The Company uses the accrual basis of accounting and accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a December 31 fiscal year end.

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $150 and $100 of cash as of December 31, 2010 and 2009, respectively.

Reclassifications

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period financial statements.

Income Taxes

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition

The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.

F-6

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2010

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Advertising Costs

The Company’s policy regarding advertising is to expense advertising when incurred. The Company incurred advertising expense of $0 and $0 during the periods ended December 31, 2010 and 2009, respectively.

Stock-Based Compensation

Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.

Basic Income (Loss) Per Share

Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of December 31, 2010.

Comprehensive Income

The Company has which established standards for reporting and display of comprehensive income, its components and accumulated balances. When applicable, the Company would disclose this information on its Statement of Stockholders’ Equity. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. The Company has not had any significant transactions that are required to be reported in other comprehensive income.

Recent Accounting Pronouncements

Core does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flow.

NOTE 2 – PREPAID CONSULTING

On November 17, 2010, the Company granted 200,000 stock options for consulting services valued at $12,000. The services had not occurred as of December 31, 2010 and the amount has been recorded as prepaid consulting. The options have an exercise price of $0.05 with 100,000 options expiring on November 17, 2011 and the remaining 100,000 options expiring on November 17, 2012. The consulting expenses are expected to occur during 2011.

NOTE 3 – ASSIGNMENT OF ACQUISITION

On December 1, 2010, the Company acquired a letter of intent from ACE Diagnostics, LLC, a shareholder of the Company, for $100,000. ACE Diagnostics, LLC had earlier entered into the letter of intent with Indian River Radiology to acquire the majority of the assets of Indian River Radiology. In the event that the acquisition is completed, the amount of the note will be applied towards the purchase price. See Note 7.

F-7

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2010

NOTE 4 – WEBSITE DOMAIN NAMES

During the year ended December 31, 2010, the Company acquired two website domain names in exchange for 1,000,000 shares of common stock valued at $0.001 per share for a total amount of $1,000. The domain names have an indefinite useful life and will be tested for impairment annually. No impairment charge was taken during the year ended December 31, 2010.

NOTE 5 – ACCRUED EXPENSES

Accrued expenses and interest consisted of the following at December 31:

	2010		2009
Accrued professional fees	$	11,375	$	3,000
Accrued wages and taxes		36,001		0
Accrued investment expenses		2,500		0
Accrued general and administrative expenses		313		0
Total accrued expenses	$	50,189	$	3,000

NOTE 6 – ACCRUED EXPENSES – RELATED PARTIES

Accrued expenses – related parties consisted of the following at December 31:

	2010		2009
Accrued consulting fees - shareholder	$	15,000	$	0
Accrued directors’ fees		9,000		0
Accrued shareholder expense reimbursement		222		0
Total accrued expenses	$	24,222	$	0

NOTE 7 – NOTES PAYABLE – SHAREHOLDERS

The Company has received various loans from Loftum, LLC totaling $17,863 as of December 31, 2010. The notes are unsecured, due on demand and bear interest at the rate of 8%. Loftum, LLC is a shareholder of the Company. Interest expense was $1,252 and $653 for the years ended December 31, 2010 and 2009, respectively. The balance due to the shareholder was $17,863 as of December 31, 2010. Accrued interest on this note was $1,955 as of December 31, 2010.

Additionally, on December 1, 2010, the Company acquired a letter of intent from ACE Diagnostics, LLC. ACE Diagnostics is a shareholder of the Company. The letter of intent required a note be issued in the amount of $100,000. The loan is unsecured, bears 6% interest beginning on January 1, 2011, and is due on demand. On December 20, 2010, the Company converted $2,250 of the note to 2,250,000 shares of common stock. The balance due to the shareholder was $97,750 as of December 31, 2010.

NOTE 8 – STOCKHOLDERS’ DEFICIT

The Company has 100,000,000 shares of par value $0.0001 common stock authorized. The Company also has 10,000,000 shares of par value $0.0001 preferred stock authorized.

At inception, the Company issued 1,000,000 shares of common stock at par value for cash proceeds of $100.

F-8

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2010

NOTE 8 – STOCKHOLDERS’ DEFICIT (CONTINUED)

On August 10, 2010, the Company issued 500,000 shares of common stock at $0.001 per share for cash proceeds of $500.

Also on August 10, 2010, the Company issued 1,000,000 shares of common stock at $0.001 per share to acquire two website domain names valued at $1,000. See Note 3.

On November 16, 2010, the Company issued 70,000 shares of common stock at $0.001 per share for cash proceeds of $70.

On November 17, 2010, the Company issued 50,000 shares of common stock at $0.05 per share for cash proceeds of $2,500.

On November 17, 2010, the Company granted 200,000 stock options for consulting services valued at $12,000. The options have an exercise price of $0.05 with 100,000 options expiring on November 17, 2011 and the remaining 100,000 options expiring on November 17, 2012. See Note 2.

On December 20, 2010, the Company issued 2,250,000 shares of common stock at $0.001 per share to convert $2,250 of the ACE Diagnostics, LLC shareholder note payable. See Note 6.

There are 4,870,000 shares of common stock outstanding as of December 31, 2010. There are no shares of preferred stock outstanding as of December 31, 2010.

NOTE 9 – COMMITMENTS

Core Health Care Network, Inc. rented office space beginning on December 1, 2010 for approximately $79 per month on a month to month basis.

Prior to December 1, 2010, an officer had provided office services without charge. Such costs are immaterial to the financial statements and accordingly are not reflected herein. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future.

NOTE 10 – INCOME TAXES

For the period ended December 31, 2010, the Company has incurred net losses and, therefore, has no tax liability. The net deferred tax asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward is approximately $97,000 at December 31, 2010, and will expire beginning in the year 2028.

The provision for Federal income tax consists of the following as of December 31:

	2010			2009
Federal income tax benefit attributable to:
Current Operations	$	27,515		$	2,472
Less: valuation allowance		(27,515	)		(2,472	)
Net provision for Federal income taxes	$	0		$	0

F-9

CORE HEALTH CARE NETWORK, INC.

(FORMERLY MICKLAND, INC.)

(A DEVELOPMENT STAGE COMPANY)

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2010

NOTE 10 – INCOME TAXES (CONTINUED)

The cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax amount is as follows at December 31:

	2010			2009
Deferred tax asset attributable to:
Net operating loss carryover	$	33,057		$	5,542
Valuation allowance		(33,057	)		(5,542	)
Net deferred tax asset	$	0		$	0

NOTE 11 – LIQUIDITY AND GOING CONCERN

Core Health Care Network, Inc. has negative working capital, has incurred operating losses since inception, and has not yet received revenues from sales of products or services. These factors create substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern.

The ability of the Company to continue as a going concern is dependent on the Company generating cash from the sale of its common stock and/or obtaining debt financing and attaining future profitable operations. Management’s plans include selling its equity securities and obtaining debt financing to fund its capital requirement and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.

NOTE 12 – SUBSEQUENT EVENTS

On January 10, 2011, the Company entered into a stock purchase agreement to acquire 100% of the issued and outstanding stock of Medtech Corporation in exchange for 1,500,000 shares of the Core’s common stock.

In accordance with SFAS 165 (ASC 855-10) the Company has analyzed its operations subsequent to December 31, 2010 to March 21, 2011, the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements other than those discussed above.

F-10

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures.

As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures at the end of the period covered by this report. This evaluation was carried out under the supervision and with the participation of our principal executive officer and chief financial officer. Based on this evaluation, we have concluded that the design and operation of our disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting or in other factors that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Disclosure controls and procedures are our controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to our management, including principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Management's Report on Internal Control over Financial Reporting

Our company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) for our company. Our company’s internal control over financial reporting is designed to provide reasonable assurance, not absolute assurance, regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. Internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States of America, and that our company’s receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

As required by Rule 13a-15(c) promulgated under the Exchange Act, our management, with the participation of our Chief Executive Officer and Principal Financial Officer, evaluated the effectiveness of our internal control over financial reporting as of December 31, 2010. Management’s assessment was based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control over Financial Reporting —Guidance for Smaller Public Companies. In performing the assessment, management has concluded that our internal control over financial reporting was effective as of December 31, 2010.

Changes in Internal Controls over Financial Reporting.

There was no change in our internal control over financial reporting during our fourth quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B.OTHER INFORMATION

None.

PART III.

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS,CONTROL PERSONS AND CORPORATE GOVERNANCE; COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT

Directors, Executive Officers

All directors of our company hold office until the annual meeting of the stockholders or until their successors have been elected and qualified.

Our directors and executive officers, their ages, positions held, and duration as such, are as follows:

Name	Position Held with the Company	Age	Date First Elected or Appointed
Pamela McClanahan	Principal Financial Officer and Secretary	43	August 10, 2010
Lewis C. Warren	Principal Executive Officer, President, and Director	49	August 10, 2010
F. Tony Hosseini	Director	52	August 10, 2010
Dr. Michael J. Langley	Director	52	August 10, 2010

Business Experience

The following is a brief account of the education and business experience during at least the past five years of each director, executive officer and key employee, indicating the principal occupation during that period, and the name and principal business of the organization in which such occupation and employment were carried out.

Lewis C. Warren, age 49, is the President and Director of the Company effective August 10, 2010. Mr. Warren’s employment is at-will. Mr. Warren is a management professional with 25-years experience in sales, marketing, and project leadership positions. He has hired and trained personnel to acquire, develop, market, and sell over $900 million of real estate holdings with $150 million in pre-tax profits as an officer of two Fortune 500 Public Companies and two Private Equity Funds. He was an integral part of building two real estate development and construction businesses to exceed $100 million in annual revenue. Mr. Warren has experience in finance and all core functions within a business. His experience is broad in residential, commercial and hospitality real estate development, construction, land planning, land acquisitions, golf course development, project due diligence, business and market evaluations, and financing. Mr. Warren also led major initiatives in the private asset management and private equity fund arenas. He was a private asset manager and financial intermediary to the real estate development industry, creating and implementing business plans that produced more than $100 million in revenue from client assets. He has arranged or syndicated acquisition and development loans of $60 million. Mr. Warren has a Masters Degree in Real Estate from LaSalle University and is a current or previous member of the North Carolina, South Carolina and Georgia Boards of Realtors, the National Home Builders Association, the American Resort Developers Association, the Urban Land Institute and the National Golf Foundation.

Pamela McClanahan, 43, is the Treasurer and Secretary of the Company effective as of August 10, 2010. Ms. McClanahan’s employment is at-will. From 2007 to present, Ms. McClanahan has acted as an independent tax and accounting consulting. She also served as a home school educator from 2006 to 2009. Prior to that, Ms. McClanahan was an elementary school teacher at Statesville Christian School in Statesville, NC.

Dr. Michael J. Langley, 52, is a Member of the Board of Directors of the Company effective as of August 10, 2010. Since 1990, Dr. Langley has headed the Urology Associates of New River Valley in Christianburg, VA. He graduated Abilene Christian College with a BS in 1980, Baylor College of Medicine with a MD in 1984, and did six years of residence at the University of Virginia Hospital.

F. Tony Hosseini, 52, is a Member of the Board of Directors of the Company effective as of August 10, 2010. Mr. Hosseini is the Founder and Chairman of FTH Group, Inc., an investment management company in South Carolina and was Founding Director of NC Selective Fund, a TPA-managed self-insurance fund underwriting worker’s compensation insurance. He was the chief executive officer of TWG Mortgage, a mortgage banking firm with offices in Ohio, North Carolina and Florida, and served as a member of Board of Directors of both Genesis Securities and Amvest, Inc., two investment banking firms in Ohio. Prior to those engagements, Mr. Hosseini gained significant experience as Securities and Pension Specialist with John Hancock Mutual Insurance Company, structuring a broad investment portfolio for the company. Mr. Hosseini also served as chief executive of Silk Road International, Inc., providing consulting services to joint ventures in developing countries in areas of energy, healthcare, housing, and other infra-structural development activities. In 2008 Mr. Hosseini co-founded Rock Communities, a wellness resort company in South Carolina. He also serves as a Director of Sina Care Centers, Inc., a holistic wellness company in Denver, Colorado that he co-founded in 1996.

Committees of the Board

We do not have an audit or compensation committee at this time.

Involvement in Certain Legal Proceedings

Our directors, executive officers and control persons have not been involved in any of the following events during the past five years:

1. any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;

2. any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

3. being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; or

4. being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

Conflict of Interest

None of our officers or directors will be subject to a conflict of interest.

ITEM 11. EXECUTIVE COMPENSATION

The following table summarizes the compensation of our President (Principal Executive Officer) and other officers and directors who received annual compensation in excess of $100,000 during the period from October 13, 2008 (inception) to December 31, 2010.

SUMMARY COMPENSATION TABLE

Name and Principal Position	Year	Annual Compensation			Long Term Compensation(1)		Pay-outs
Name and Principal Position	Year	Salary	Bonus	Other Annual Compen- sation(2)	Securities Under Options/ SAR's Granted	Restricted Shares or Restricted Share Units	LTIP Pay- outs	All Other Compen- sation
Patti Johnson, President, Treasurer, Secretary, Director	2008	Nil	Nil	Nil	Nil	Nil	Nil	Nil
	2009	Nil	Nil	Nil	Nil	Nil	Nil	Nil
	2010	Nil	Nil	Nil	Nil	Nil	Nil	Nil
Pam McClanahan, Secretary and Treasurer	2010	Nil	Nil	Nil	Nil	Nil	Nil	Nil
Lewis C. Warren, President and Director	2010	Nil	Nil	Nil	Nil	Nil	Nil	Nil
Dr. Michael J. Langley, Director	2010	Nil	Nil	Nil	Nil	Nil	Nil	Nil
F. Tony Hosseini, Director	2010	Nil	Nil	Nil	Nil	Nil	Nil	Nil

Until October 1, 2010, we had not entered into any employment agreement or consulting agreement with our directors and executive officers. On October 1, 2010, we entered into employment agreements with our two officers. Pam McClanahan, our secretary and treasurer, shall receive $3,500 per month and our president, Lewis C. Warren shall receive $7,500 per month. Starting on the same date, the board members agreed to receive $1,000 per month for compensation for their service as board members. To date, no officers or directors have received any compensation under any agreement although it has accrued.

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. Our directors and executive officers may receive stock options at the discretion of our board of directors in the future, although no stock option plan is currently in place. We do not have any material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at the discretion of our board of directors.

Directors Compensation

On October 1, 2010, the board members agreed to receive $1,000 per month for compensation for their service as board members. To date, no officers or directors have received any compensation under any agreement although their compensation is accruing.

We have not reimbursed our directors for expenses incurred in connection with attending board meetings nor have we paid any directors fees or other cash compensation for services rendered as a director in the period ended December 31, 2010 although such costs are accruing.

In the future we may grant options to our directors to purchase shares of common stock as determined by our Board of Directors or a compensation committee that may be established. We do not, however, have a stock option plan in place at this time. Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of our board of directors. The board of directors may award special remuneration to any director undertaking any special services on behalf of Core other than services ordinarily required of a director. Other than as indicated in this prospectus, no director received and/or accrued any compensation for his or her services as a director, including committee participation and/or special assignments

ITEM 12.　SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Principal Stockholders

The following table sets forth, as of December 31, 2010, certain information with respect to the beneficial ownership of our common stock by each stockholder known by us to be the beneficial owner of more than 5% of our common stock and by each of our current directors and executive officers. Each person has sole voting and investment power with respect to the shares of common stock, except as otherwise indicated. Beneficial ownership consists of a direct interest in the shares of common stock, except as otherwise indicated.

Name of Beneficial Owner(1)	Amount and Nature of Beneficial Ownership	Percentage of Class(2)
Loftum, LLC	2,000,000	41.07%
F. Tony Hosseini	1,060,000	21.77%
Lewis C. Warren	1,040,000	21.36%
Pamela McClanahan	300,000	6.16%

Beneficial Owners, Directors and Executive Officers as a Group	4,400,000 common shares	90.35%

(1)	Unless otherwise stated, the beneficial owner’s address is 200 S. Virginia Street – 8th Floor, Reno, NV, 89501

(2)

Based on 4,870,000 shares of common stock issued and outstanding as of December 31, 2010. Except as otherwise indicated, we believe that the beneficial owners of the common stock listed above, based on information furnished by such owners, have sole investment and voting power with respect to such shares, subject to community property laws where applicable. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities.

(3)	The manager of Loftum, LLC is Pam McClanahan.

Changes in Control

We are unaware of any contract or other arrangement the operation of which may at a subsequent date result in a change of control of CORE.

ITEM 13.　CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

We entered into a promissory note for $100,000 with Ace Diagnostics on December 20, 2010 in exchange for ACE Diagnostics, interest in a letter of intent with Indian River Radiology. ACE Diagnostics is managed by director, F. Tony Hosseini.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

(1) 　 Audit Fees

The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for our audit of annual financial statements and review of financial statements included in our Form 10-Qs or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years was:

	2009	$	4,000		Silberstein Ungar, PLLC
	2010	$	9,500		Silberstein Ungar, PLLC

(2) 　 Audit-Related Fees

The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountants that are reasonably related to the performance of the audit or review of our financial statements and are not reported in the preceding paragraph:

	2009	$	Nil		Silberstein Ungar, PLLC
	2010	$	Nil		Silberstein Ungar, PLLC

(3) 　 Tax Fees

The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning was:

	2009	$	Nil		Silberstein Ungar, PLLC
	2010	$	Nil		Silberstein Ungar, PLLC

(4) 　 All Other Fees

The aggregate fees billed in each of the last two fiscal years for the products and services provided by the principal accountant, other than the services reported in paragraphs (1), (2), and (3) was:

	2009	$	Nil		Silberstein Ungar, PLLC
	2010	$	Nil		Silberstein Ungar, PLLC

(5) 　 Our audit committee's pre-approval policies and procedures described in paragraph (c)(7)(i) of Rule 2-01 of Regulation S-X were that the audit committee pre-approve all accounting related activities prior to the performance of any services by any accountant or auditor.

(6) 　 The percentage of hours expended on the principal accountant's engagement to audit our financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant's full time, permanent employees was 0%.

PART IV.

ITEM 15.　Exhibits and Reports on Form 10-K

The following Exhibits are incorporated herein by reference from the Registrant's Form 10 Registration Statement filed with the Securities and Exchange Commission, SEC file # 000-53714 on July 6, 2009. Such exhibits are incorporated herein by reference pursuant to Rule 12b-32:

Exhibit No.		Document Description
3.1		Articles of Incorporation.
3.2		Bylaws.

The following documents are included herein:

Exhibit No.		Document Description
23.1		Consent of Independent Registered Public Accounting Firm.
31.1		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.
32.1		Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer and Chief Financial Officer).

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CORE HEALTH CARE NETWORK, INC.

Date: April 13, 2011	By:	/s/ Pamela McClanahan
		Name: Pamela McClanahan
		Title: Chief Financial Officer and Secretary



	By:	/s/ Lewis C. Warren
		Name: Lewis C. Warren
		Title: Chief Executive Officer and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.


April 13, 2011	By:	/s/ Pamela McClanahan
		Name: Pamela McClanahan
		Title: Chief Financial Officer and Secretary

	Company Name

April 13, 2011	By:	/s/ Lewis C. Warren
		Name: Lewis C. Warren
		Title: Chief Executive Officer and Director

Number of

securities to be

issued upon

exercise of

outstanding

options,

warrants and

rights (a)

Weighted

average

exercise

price of

outstanding

options,

warrants

and rights

(b)

Number of securities

remaining available

for future issuances

under equity

compensation plans

(excluding securities

reflected in column

(a)) (c)

Equity compensation plans approved by security holders

Equity compensation plans not approved by security holders